Jennifer Tursi
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 7
- Gastric Cancer Management and Outcomes 6
- Lung Cancer Diagnosis and Treatment 5
- Advanced Breast Cancer Therapies 3
- Oncology top 1%
- Colorectal Cancer Treatments and Studies 10
- Lung Cancer Research Studies 4
- Cancer Treatment and Pharmacology 3
- Cancer Research top 2%
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment 3
Jennifer Tursi
24 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Pulmonary and Respiratory Medicine 2.5k
- Oncology 2.1k
- Cancer Research 681
- Pathology and Forensic Medicine 299
- Gastroenterology 68
Countries citing papers authored by Jennifer Tursi
This map shows the geographic impact of Jennifer Tursi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Tursi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Tursi more than expected).
Fields of papers citing papers by Jennifer Tursi
This network shows the impact of papers produced by Jennifer Tursi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Tursi. The network helps show where Jennifer Tursi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jennifer Tursi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2021 | 29 | |
| 3 | 2019 | 10 | |
| 4 | 2016 | 191 | |
| 5 | Intracranial efficacy of first-line crizotinib vs. chemotherapy in ALK-positive NSCLC | 2015 | 1 |
| 6 | First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancerbreakdown → | 2014 | 2327 |
| 7 | 2014 | 2 | |
| 8 | 2014 | 53 | |
| 9 | 2014 | 10 | |
| 10 | 2012 | 15 | |
| 11 | ASSOCIATIONS BETWEEN GERMLINE GENOTYPE AND EFFICACY AND SAFETY OUTCOMES IN A PHASE III STUDY OF SUNITINIB AND FOLFIRI IN METASTATIC COLORECTAL CANCER (MCRC) | 2011 | 1 |
| 12 | 2011 | 21 | |
| 13 | 2010 | 153 | |
| 14 | 2007 | 3 | |
| 15 | 2007 | 2 | |
| 16 | 2003 | 31 | |
| 17 | 2003 | 24 | |
| 18 | 2001 | 48 | |
| 19 | 1994 | 12 | |
| 20 | 1986 | 90 |
About Jennifer Tursi
Jennifer Tursi is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 3.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Treatments and Mutations (7 papers), Gastric Cancer Management and Outcomes (6 papers), Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Research Studies (4 papers), Advanced Breast Cancer Therapies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Gastrointestinal Tumor Research and Treatment (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.5k citations), Oncology (2.1k citations) and Cancer Research (681 citations). Jennifer Tursi has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Enriqueta Felip, Tony Mok, Benjamin Solomon, Jolanda Paolini, Yi‐Long Wu, Tarek Mekhail, Tiziana Usari, Fiona Blackhall, Federico Cappuzzo and Kazuhiko Nakagawa. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Investigational New Drugs, British Journal of Cancer and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.